Ben Lerer, Lerer Hippeau managing director, joins 'Squawk on the Street' to discuss his outlook for the IPO market what's ...

Australia's securities regulator said on Tuesday it would trial changes to speed up initial public offerings that are at a ...

Insurance tech company Slide is aiming for a valuation of up to $2.12 billion in its U.S. initial public offering, joining a ...

(Reuters) -Cancer diagnostic firm Caris Life Sciences said on Monday it is targeting a valuation of up to $5.35 billion in ...

Slide Insurance Holdings Inc. and some of its investors are seeking to raise $340 million in an initial public offering, ...

IPO offers diversified exposure to newly public companies, with a balanced mix of value, blend, and growth. Read why I'm ...

Circle stock continued to surge on Monday for a third day in a row following the stablecoin issuer's blockbuster IPO last ...

The trial measures will accelerate listings and represent the biggest changes to the process for almost a decade.

Chairman Joe Longo cannot fix the fact private markets will pay more for smaller businesses than public markets, but he can ...

Lenskart has converted to a public entity as it prepares for a potential $1-billion IPO, aiming for a $10 billion valuation.

Get the latest on the Sacheerome IPO including grey market premium (GMP), expected listing price, and probable listing date.

The chronic condition management company’s debut comes weeks after another digital health company, Hinge Health, went public.